Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program

QR Code

Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program

Background & Aims: Several countries have implemented programs to screen for colorectal cancer (CRC) by using the fecal immunochemical test (FIT). These programs vary considerably in age of the population screened and the cutoff concentration of fecal hemoglobin (Hb) used to identify candidates...

Full description

Bibliographic Details
Main Authors:	Wieten, E., Schreuders, E., Nieuwenburg, S., Hansen, B., Lansdorp_Vogelaar, Iris, Kuipers, E., Bruno, M., Spaander, M.
Format:	Journal Article
Published:	W.B. Saunders Co 2016
Online Access:	http://hdl.handle.net/20.500.11937/49881

Similar Items

Fecal immunochemical test-based colorectal cancer screening: The gender dilemma
by: Grobbee, E., et al.
Published: (2017)

Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)

Immunochemical faecal occult blood testing to screen for colorectal cancer: Can the screening interval be extended?
by: Haug, U., et al.
Published: (2016)

Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening
by: Van Der Vlugt, M., et al.
Published: (2017)

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)

Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)

Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing
by: van der Vlugt, M., et al.
Published: (2017)

Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)

Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening
by: Grobbee, E., et al.
Published: (2015)

Do men and women need to be screened differently with fecal immunochemical testing? A cost-effectiveness analysis
by: Van Der Meulen, M., et al.
Published: (2017)

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
by: Grobbee, E., et al.
Published: (2016)

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)

Assessment of a cancer screening program
by: Rabeneck, L., et al.
Published: (2015)

Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)

Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia
by: Kapidzic, A., et al.
Published: (2015)

Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)

Population-Based colonoscopy screening for colorectal cancer : A randomized clinical trial
by: Bretthauer, M., et al.
Published: (2016)

Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Fecal occult blood testing when colonoscopy capacity is limited
by: Wilschut, J., et al.
Published: (2011)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)

Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
by: Brenner, H., et al.
Published: (2011)

Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)

State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)

Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)

Colorectal cancer screening using immunochemical fecal occult blood test
by: Tan, Mun Chieng, et al.
Published: (2017)

Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)

The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)

Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015)

Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer
by: Kapidzic, A., et al.
Published: (2015)

Integrating personalised genomics into risk stratification models of population screening for colorectal cancer
by: Cenin, Dayna, et al.
Published: (2017)

Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
by: Gini, A., et al.
Published: (2018)

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
by: Cenin, Dayna, et al.
Published: (2018)

Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)

The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)

Optimal colorectal cancer screening in states' low-income, uninsured populations - The case of South Carolina
by: Van Der Steen, A., et al.
Published: (2015)